EKYMED SRL

Their core work

EKYMED is a Milan-based medical technology SME working at the intersection of photonics, robotics, and minimally invasive surgery. Their flagship innovation, SWeetLight, applies light-based techniques to tissue suturing — replacing conventional needle-and-thread approaches with a photonic process that reduces trauma and improves precision in wound closure. As a participant in the Endoo consortium, they contributed to the development of magnetically driven, soft-tethered robotic endoscopes for diagnosis and therapy deep within the gastrointestinal tract. Despite being categorized under ICT in the H2020 taxonomy due to their robotics and photonics components, their real-world domain is surgical medical devices for clinical use.

What they specialise in

How they've shifted over time

Both of EKYMED's H2020 projects were initiated in 2015, which makes a meaningful before-and-after evolution analysis impossible — there is no discernible shift in focus between an early and a late phase. What can be observed is a dual-track approach at launch: leading a small feasibility study on their own photonic suturing technology while simultaneously embedding into a larger robotic endoscopy consortium as a specialist contributor. No H2020 project activity appears after 2015, so whether the company deepened, pivoted, or scaled any of these directions post-Endoo cannot be determined from available data.

With no projects beyond 2015 visible in H2020 data, the direction is unclear; any future collaborator should verify whether SWeetLight advanced past feasibility stage and whether Endoo outputs translated into commercial products.

How they like to work

EKYMED is comfortable in both the coordinator seat (leading the SWeetLight feasibility study independently) and as a targeted specialist contributor within a larger consortium (Endoo). Their overall H2020 footprint — 9 unique partners across 3 countries — is small and selective, suggesting they form partnerships based on specific technical fit rather than opportunistic network-building. This points to an organization that will add focused, deep expertise to a consortium rather than broad generalist capacity.

EKYMED has engaged with 9 unique partners across 3 countries, a compact network consistent with a highly specialized medical device SME that collaborates within defined clinical and engineering ecosystems. Their Italian base in Milano positions them within one of Europe's strongest medical technology clusters, likely anchoring their network in northern Italian and broader European medtech partnerships.

What sets them apart

EKYMED occupies a narrow but genuinely differentiated niche: applying photonic principles to surgical suturing, a space where very few SMEs have staked a claim in H2020 funding. Their simultaneous entry into robotic endoscopy via Endoo signals access to high-level clinical and engineering partners, which is unusual for a company this small. For consortium builders in surgical robotics, endoluminal devices, or medical photonics, EKYMED offers focused IP-level expertise rather than generic software or systems integration capacity.

Highlights from their portfolio

• Endoo
  The largest grant in their portfolio (EUR 232,575) and an Innovation Action — a more demanding funding type than feasibility studies — placing EKYMED inside a multi-country consortium tackling magnetically driven soft-tethered endoluminal robotics, one of the more technically ambitious areas in H2020 medical robotics.
• SWeetLight
  Notable for the coordinator role and the concept itself — applying light to replace mechanical suturing in surgery — a sufficiently distinctive idea to earn SME Instrument Phase 1 validation, which historically had a competitive acceptance rate below 10%.